文献速递头颈泌尿生殖技术与安全US

多模态超声影像组学模型鉴别颈部淋巴结良恶性

A Multimodal Ultrasound Radiomics Model Integrating Contrast-Enhanced Phases: Retrospective Temporal Test Cohort Evaluation and Comparison with Sonographers for Cervical Lymph Node Characterization.
PubMed 文献 · Acad Radiol · 2026-08-03

本研究开发基于二维超声、彩色多普勒及三相超声造影的影像组学模型,用于区分颈部淋巴结良恶性。在时间独立测试队列中评估模型与不同年资超声医师的诊断效能,模型AUC为0.851。研究为回顾性单中心设计,缺乏前瞻性外部验证。

要点

  • 超声造影三相关键帧整合模型在时间测试队列AUC达0.851,敏感度84.8%。
  • 模型敏感度数值上高于两位超声医师,但特异度低于高年资医师。
  • 该模型仅作为假设生成性辅助工具,临床使用前需多中心前瞻性验证。

核心结论

  • 整合超声造影关键帧信息的多模态超声影像组学模型在回顾性时间测试队列中展现了可行的诊断性能。
  • 该模型可能作为颈部淋巴结评估的假设生成性辅助工具。

研究设计与样本

  • 每位患者仅分析一个目标淋巴结,两个队列在患者层面严格不重叠。
  • 采用冻结的预训练ResNet50从手动勾画的感兴趣区中提取深度特征。
  • 特征选择、超参数调优和决策阈值锁定仅在开发队列中完成,时间测试队列仅用于最终报告。

关键影像表现/征象

  • 每例采集匹配的二维超声、彩色多普勒血流成像以及动脉期、实质期和廓清期超声造影关键帧。
  • 超声医师在盲法条件下以随机顺序审阅相同的静态关键帧图像集。

诊断标准与关键数值

  • 整合超声造影的SVM模型(Model 2-SVM)在测试队列中AUC为0.851(95%CI:0.762-0.940)。
  • Model 2-SVM敏感度为84.8%(95%CI:69.1-93.3),特异度为66.7%(95%CI:47.8-81.4)。
  • Model 2-SVM准确率为76.7%(95%CI:64.6-85.6),阳性预测值为75.7%(95%CI:59.9-86.6),阴性预测值为78.3%(95%CI:58.1-90.3)。
  • 高年资超声医师AUC为0.826,低年资超声医师AUC为0.783。
  • 在锁定验证阈值下,模型敏感度数值上高于两位超声医师,但特异度低于高年资超声医师。

临床应用与阅片要点

  • 在日常阅片时,该模型可尝试作为颈部淋巴结定性诊断的参考意见,不替代超声医师综合判断。
  • 需注意该模型为回顾性单中心开发,用于其他中心或不同设备时尚未验证。

局限性

  • 研究为回顾性单中心设计,ROI勾画依赖人工,且缺乏前瞻性外部验证。
  • 结果在临床应用前需要多中心进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop a multimodal ultrasound radiomics model based on conventional ultrasound and three-phase contrast-enhanced ultrasound (CEUS) for distinguishing benign from malignant cervical lymph nodes, and to evaluate its performance in a patient-level temporal test cohort against sonographers with different experience levels.

MATERIALS AND METHODS: This retrospective study included 245 patients in the development cohort (August 2022-December 2024) and 60 subsequent patients in the temporal test cohort (January-December 2025). One target lymph node was analyzed per patient, and the two cohorts were strictly non-overlapping at the patient level. For each case, matched two-dimensional ultrasound (2D-US), color Doppler flow imaging (CDFI), and arterial-, parenchymal-, and clearance-phase CEUS key frames were collected. Deep features were extracted from manually cropped ROIs using a frozen pre-trained ResNet50. Feature selection, hyperparameter tuning, and decision-threshold locking were completed only within the development cohort; the temporal test cohort was used once for final reporting. Sonographers reviewed the same static key-frame image set in randomized order under blinded conditions.

RESULTS: The CEUS-integrated SVM model (Model 2-SVM) showed the best overall performance among the tested models. In the temporal test cohort, it achieved an area under the curve (AUC) of 0.851 (95% CI: 0.762-0.940), sensitivity of 84.8% (95% CI: 69.1-93.3), specificity of 66.7% (95% CI: 47.8-81.4), accuracy of 76.7% (95% CI: 64.6-85.6), PPV of 75.7% (95% CI: 59.9-86.6), and NPV of 78.3% (95% CI: 58.1-90.3). The senior and junior sonographers achieved AUCs of 0.826 and 0.783, respectively. At the validation-locked threshold, the model showed numerically higher sensitivity than both sonographers but lower specificity than the senior sonographer. Threshold-free and paired statistical comparisons are reported in the corresponding tables.

CONCLUSION: A multimodal ultrasound radiomics model incorporating CEUS key-frame information demonstrated feasible diagnostic performance in a retrospective temporal test cohort and may serve as a hypothesis-generating adjunct for cervical lymph node assessment. This retrospective single-center design, manual ROI delineation, and the absence of prospective external validation require further multi-center evaluation before clinical application.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Gao, Lv, Hao, et al. A Multimodal Ultrasound Radiomics Model Integrating Contrast-Enhanced Phases: Retrospective Temporal Test Cohort Evaluation and Comparison with Sonographers for Cervical Lymph Node Characterization. Acad Radiol. 2026. PMID: 42547384. doi:10.1016/j.acra.2026.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。